Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.855 USD | -1.79% | -26.14% | -37.99% |
May. 15 | HC Wainwright Adjusts Fennec Pharmaceuticals Price Target to $15 From $18, Maintains Buy Rating | MT |
May. 14 | Transcript : Fennec Pharmaceuticals Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.99% | 191M | |
+7.17% | 113B | |
+11.22% | 106B | |
+0.32% | 22.27B | |
-12.00% | 22.22B | |
-5.99% | 19.43B | |
-37.85% | 17.87B | |
-6.32% | 17.24B | |
+7.41% | 14.29B | |
+35.26% | 12.52B |
- Stock Market
- Equities
- FENC Stock
- News Fennec Pharmaceuticals Inc.
- Fennec Pharmaceuticals Reports Pedmark Net Product Revenue of US$6.5 Million In Q3 2023